Husseini Manji, M.D., global head of neuroscience at Janssen Research & Development, LLC, has pioneered a ketamine-based nasal spray that has swiftly alleviated depressive symptoms in patients who have not responded to other medications. Dr. Manji is a former NIMH fellow, lab chief and director of NIH’s Mood and Anxiety Disorders Program.
Study details: [ Ссылка ]
Free ebook from Understanding Depression: [ Ссылка ]
Please become a Patron: [ Ссылка ]
Sign up for our Morning Buzz Newsletter: [ Ссылка ]
Support Actify on Social Media:
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
Youtube: [ Ссылка ]
